On November 25, 2024, Kathleen Rickard, the Chief Medical Officer of Verona Pharma PLC, sold 240,000 shares of the company. Following this transaction, the insider now owns 2,671,480 shares of Verona Pharma PLC. The details of this transaction can be found in the SEC Filing.
Verona Pharma PLC (VRNA, Financial) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.
Over the past year, Kathleen Rickard has sold a total of 312,496 shares and has not purchased any shares. The insider transaction history for Verona Pharma PLC indicates there have been 4 insider buys and 17 insider sells over the same period.
On the day of the recent sale, shares of Verona Pharma PLC were trading at $4.90 each, giving the stock a market cap of $3.26 billion.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
